[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

e-Pharma-EMEA Market Status and Trend Report 2013-2023

March 2018 | 148 pages | ID: EDD247F76D1MEN
MIReports Co., Limited

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

e-Pharma-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on e-Pharma industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole EMEA and Regional Market Size of e-Pharma 2013-2017, and development forecast 2018-2023
Main market players of e-Pharma in EMEA, with company and product introduction, position in the e-Pharma market
Market status and development trend of e-Pharma by types and applications
Cost and profit status of e-Pharma, and marketing status
Market growth drivers and challenges

The report segments the EMEA e-Pharma market as:

EMEA e-Pharma Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa

EMEA e-Pharma Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
OTC
Prescription

EMEA e-Pharma Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Patients
Others

EMEA e-Pharma Market: Players Segment Analysis (Company and Product introduction, e-Pharma Sales Volume, Revenue, Price and Gross Margin):
AbbVie Contract Manufacturing
Aurobindo Pharma
Boehringer Ingelheim
CVS Health
DocMorris
Express Scripts Holding Company
Giant Eagle, Inc.
Optum Rx, Inc.
Pfizer CentreSource
Rowlands Pharmacy
The Kroger Co.
Walgreen Co.
Walmart Stores, Inc.

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF E-PHARMA

1.1 Definition of e-Pharma in This Report
1.2 Commercial Types of e-Pharma
  1.2.1 OTC
  1.2.2 Prescription
1.3 Downstream Application of e-Pharma
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Patients
  1.3.4 Others
1.4 Development History of e-Pharma
1.5 Market Status and Trend of e-Pharma 2013-2023
  1.5.1 EMEA e-Pharma Market Status and Trend 2013-2023
  1.5.2 Regional e-Pharma Market Status and Trend 2013-2023

CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of e-Pharma in EMEA 2013-2017
2.2 Consumption Market of e-Pharma in EMEA by Regions
  2.2.1 Consumption Volume of e-Pharma in EMEA by Regions
  2.2.2 Revenue of e-Pharma in EMEA by Regions
2.3 Market Analysis of e-Pharma in EMEA by Regions
  2.3.1 Market Analysis of e-Pharma in Europe 2013-2017
  2.3.2 Market Analysis of e-Pharma in Middle East 2013-2017
  2.3.3 Market Analysis of e-Pharma in Africa 2013-2017
2.4 Market Development Forecast of e-Pharma in EMEA 2018-2023
  2.4.1 Market Development Forecast of e-Pharma in EMEA 2018-2023
  2.4.2 Market Development Forecast of e-Pharma by Regions 2018-2023

CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole EMEA Market Status by Types
  3.1.1 Consumption Volume of e-Pharma in EMEA by Types
  3.1.2 Revenue of e-Pharma in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
  3.2.1 Market Status by Types in Europe
  3.2.2 Market Status by Types in Middle East
  3.2.3 Market Status by Types in Africa
3.3 Market Forecast of e-Pharma in EMEA by Types

CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of e-Pharma in EMEA by Downstream Industry
4.2 Demand Volume of e-Pharma by Downstream Industry in Major Countries
  4.2.1 Demand Volume of e-Pharma by Downstream Industry in Europe
  4.2.2 Demand Volume of e-Pharma by Downstream Industry in Middle East
  4.2.3 Demand Volume of e-Pharma by Downstream Industry in Africa
4.3 Market Forecast of e-Pharma in EMEA by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF E-PHARMA

5.1 EMEA Economy Situation and Trend Overview
5.2 e-Pharma Downstream Industry Situation and Trend Overview

CHAPTER 6 E-PHARMA MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA

6.1 Sales Volume of e-Pharma in EMEA by Major Players
6.2 Revenue of e-Pharma in EMEA by Major Players
6.3 Basic Information of e-Pharma by Major Players
  6.3.1 Headquarters Location and Established Time of e-Pharma Major Players
  6.3.2 Employees and Revenue Level of e-Pharma Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 E-PHARMA MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 AbbVie Contract Manufacturing
  7.1.1 Company profile
  7.1.2 Representative e-Pharma Product
  7.1.3 e-Pharma Sales, Revenue, Price and Gross Margin of AbbVie Contract Manufacturing
7.2 Aurobindo Pharma
  7.2.1 Company profile
  7.2.2 Representative e-Pharma Product
  7.2.3 e-Pharma Sales, Revenue, Price and Gross Margin of Aurobindo Pharma
7.3 Boehringer Ingelheim
  7.3.1 Company profile
  7.3.2 Representative e-Pharma Product
  7.3.3 e-Pharma Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.4 CVS Health
  7.4.1 Company profile
  7.4.2 Representative e-Pharma Product
  7.4.3 e-Pharma Sales, Revenue, Price and Gross Margin of CVS Health
7.5 DocMorris
  7.5.1 Company profile
  7.5.2 Representative e-Pharma Product
  7.5.3 e-Pharma Sales, Revenue, Price and Gross Margin of DocMorris
7.6 Express Scripts Holding Company
  7.6.1 Company profile
  7.6.2 Representative e-Pharma Product
  7.6.3 e-Pharma Sales, Revenue, Price and Gross Margin of Express Scripts Holding Company
7.7 Giant Eagle, Inc.
  7.7.1 Company profile
  7.7.2 Representative e-Pharma Product
  7.7.3 e-Pharma Sales, Revenue, Price and Gross Margin of Giant Eagle, Inc.
7.8 Optum Rx, Inc.
  7.8.1 Company profile
  7.8.2 Representative e-Pharma Product
  7.8.3 e-Pharma Sales, Revenue, Price and Gross Margin of Optum Rx, Inc.
7.9 Pfizer CentreSource
  7.9.1 Company profile
  7.9.2 Representative e-Pharma Product
  7.9.3 e-Pharma Sales, Revenue, Price and Gross Margin of Pfizer CentreSource
7.10 Rowlands Pharmacy
  7.10.1 Company profile
  7.10.2 Representative e-Pharma Product
  7.10.3 e-Pharma Sales, Revenue, Price and Gross Margin of Rowlands Pharmacy
7.11 The Kroger Co.
  7.11.1 Company profile
  7.11.2 Representative e-Pharma Product
  7.11.3 e-Pharma Sales, Revenue, Price and Gross Margin of The Kroger Co.
7.12 Walgreen Co.
  7.12.1 Company profile
  7.12.2 Representative e-Pharma Product
  7.12.3 e-Pharma Sales, Revenue, Price and Gross Margin of Walgreen Co.
7.13 Walmart Stores, Inc.
  7.13.1 Company profile
  7.13.2 Representative e-Pharma Product
  7.13.3 e-Pharma Sales, Revenue, Price and Gross Margin of Walmart Stores, Inc.

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF E-PHARMA

8.1 Industry Chain of e-Pharma
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF E-PHARMA

9.1 Cost Structure Analysis of e-Pharma
9.2 Raw Materials Cost Analysis of e-Pharma
9.3 Labor Cost Analysis of e-Pharma
9.4 Manufacturing Expenses Analysis of e-Pharma

CHAPTER 10 MARKETING STATUS ANALYSIS OF E-PHARMA

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications